Urgent Action Needed to Spur Antibiotic Innovation

Updated research from Pew and the WHO in the Global AMR R&D Hub shows not enough drugs are in development to meet patient needs

Urgent Action Needed to Spur Antibiotic Innovation

The World Health Organization, The Pew Charitable Trusts, and Global AMR R&D Hub are urging policymakers and innovation stakeholders to stimulate the insufficient global antibiotic pipeline. The call to action follows analyses from the WHO and Pew released earlier this year—and compiled in a Dynamic Dashboard by Global AMR R&D Hub—that conclude there are not enough new antibiotics in clinical development to meet patient needs worldwide.

National Homeownership Month

Article

37 Researchers Working to Transform Biomedical Science

Quick View
Article

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.